Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation

Journal of Translational Medicine

Review

Iris Sheng¹  Seah H. Lim¹  Vikram M. Raghunathan¹ 

[1] Division of Hematology and Oncology, Department of Medicine, Rhode Island Hospital, Room 140 APC Building, 593 Eddy Street, 02903, Providence, RI, USA;Brown University Warren Alpert School of Medicine, Providence, USA;

关键词: Stem Cell Transplant;    Clostridium Difficile Infection;    Short Chain Fatty Acid;    Intestinal Microbiota;    Acute GVHD;   

DOI  :  10.1186/s12967-016-1094-3

 received in 2016-10-24, accepted in 2016-11-23,  发布年份 2016

来源: Springer

【 摘 要 】

The intestinal microbiota is a diverse and dynamic ecosystem that is increasingly understood to play a vital role in human health. Hematopoietic stem cell transplant recipients undergo prolonged exposure to antimicrobials, chemotherapeutic agents, and immunosuppressants, resulting in profound shifts in the gut microbiome. A growing body of research has revealed the ways in which these microbiologic shifts shape immune modulation, affecting susceptibility to infections and graft-versus-host disease, the two major post-transplant complications in this population. As transplant medicine becomes increasingly personalized, the potential for microbiome-modulating treatments holds immense potential. Strategies to preserve the intestinal microbiota, including targeted antibiotics, prebiotics and probiotics, and fecal microbiota transplant could mitigate some of the microbiologic shifts in stem cell transplant recipients, and reduce the incidence of peri-transplant morbidity and mortality.

【 授权许可】

CC BY   
© The Author(s) 2016